Bentley Pharmaceuticals was founded in 1974. Bentley Pharmaceuticals sold its French subsidiary, Chimos/LBF S.A. on June 26, 1997. The company held a secondary stock offering in April 2002. The Company manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases. Bentley's drug delivery technology is focused on improving the delivery of pharmaceuticals and peptides through a broad range of proprietary drug delivery technologies.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Bentley Pharmaceuticals
Bentley Park
2 Holland Way
Exeter
New Hampshire
03833 New Hampshire
All rights reserved. Terms and Conditions | Contact us
